Senate Bill #170 (2021)
AN ACT RELATING TO INSURANCE -- PRESCRIPTION DRUG BENEFITS
Limits health insurance carriers that provide coverage for prescription insulin drugs used to treat diabetes to forty dollars ($40) for a copayment for a thirty (30) day supply of medically necessary insulin.
View latest version |
View original version
View status on official RI website
Subscribe to email updates
-
2021-02-05: Introduced, referred to Senate Health and Human Services
-
2021-03-12: Scheduled for hearing and/or consideration (03/18/2021)
[Show]
-
2021-03-18: Committee recommended measure be held for further study
-
2021-05-21: Scheduled for consideration (05/27/2021)
[Show]
-
2021-05-26: Proposed Substitute
-
2021-05-27: Committee recommends passage of Sub A
-
2021-05-28: Placed on Senate Calendar (06/01/2021)
[Show]
-
2021-06-01: Senate passed Sub A
-
2021-06-02: Referred to House Health & Human Services
-
2021-06-11: Scheduled for consideration (06/14/2021)
[Show]
-
2021-06-11: Proposed Substitute
-
2021-06-14: Committee recommends passage of Sub B
-
2021-06-22: Placed on House Calendar (06/23/2021)
[Show]
-
2021-06-23: House passed Sub B
-
2021-06-25: Placed on Senate Calendar (06/29/2021)
[Show]
-
2021-06-29: Transmitted to Governor
-
2021-06-29: Senate passed Sub B in concurrence
-
2021-07-02: Signed by Governor
Changes since original draft
2021 – S 0170- 2021 – S 0170 SUBSTITUTE B
- ========
LC001009- LC001009/SUB B
- ========
S T A T E O F R H O D E I S L A N D- S T A T E O F R H O D E I S L A N D
- IN GENERAL ASSEMBLY
- JANUARY SESSION, A.D. 2021
- ____________
A N A C T- A N A C T
- RELATING TO INSURANCE – PRESCRIPTION DRUG BENEFITS
- Introduced By: Senators Murray, McCaffrey, Miller, Goodwin, Mack, Lawson,Kallman,
Bell, Valverde, and Goldin- Bell, Valverde, and Goldin
- Date Introduced: February 05, 2021
- Referred To: Senate Health & Human Services
- It is enacted by the General Assembly as follows:
- SECTION 1. Chapter 27-20.8 of the General Laws entitled "Prescription Drug Benefits" is hereby amended by adding thereto the following section:
- 27-20.8-3. Co-pay cap for prescription insulin.
- (a)Asusedinthissection,unlessthecontextotherwiserequires,"prescriptioninsulindrug" meansaprescriptiondrug,asdefinedin§21-31-2,thatcontainsinsulinandisusedtotreat diabetes.
(b) A carrier that provides coverage for prescription insulin drugs pursuant to the terms of a health coverage plan the carrier offers shall cap the total amount that a covered person is required to pay for a covered prescription insulin drug at an amount not to exceed fifty dollars ($50.00), per thirty (30) day supply of insulin, regardless of the amount or type of insulin needed to fill the covered person's prescription. Coverage for prescription insulin drugs shall not be subject to any deductible. (c) Nothing in this section prevents a carrier from reducing a covered person's cost sharing to an amount less than the amount specified in subsection (b) of this section. (d) The health insurance commissioner may use any of their enforcement powers to obtain a carrier's compliance with this section. (e) The commissioner may promulgate rules as necessary to implement and administer this section and to align with federal requirements. SECTION 2. This act shall take effect on January 1, 2022. ======== LC001009 ========- (b) Ahealth planthat provides coverage for prescription insulin drugs pursuant tothe terms of a health coverage plan the health plan offers shall cap the total amount that a covered person is required to pay for a covered prescription insulin drug at an amount not to exceed forty dollars ($40.00), per thirty (30) day supply of insulin. Coverage for prescription insulin drugs shall not be subject to any deductible.
- (c) Nothing in this section prevents a health plan from reducing a covered person's cost sharing to an amount less than the amount specified in subsection (b) of this section.
- (d)The office of the healthinsurancecommissioner mayuse anyof itsenforcement powers to obtain a health plan's compliance with this section.
- (e) The office of the health insurance commissioner may promulgate rules and regulations as necessary to implement and administer this section and to align with federal requirements.
- SECTION 2. This act shall take effect on January 1, 2022. ======== LC001009/SUB B ========
- EXPLANATION
- BY THE LEGISLATIVE COUNCIL
- OF
- A N A C T
- RELATING TO INSURANCE – PRESCRIPTION DRUG BENEFITS
- ***
This act would provide that health insurance carriers that provide coverage for prescription insulin drugs used to treat diabetes shall only be allowed to charge up to fifty ($50.00) dollars for a copayment for a thirty (30) day supply of insulin regardless of the amount or type of insulin needed to fill the covered person's prescription. Coverage for prescription insulin would not be subject to any deductible. This act would take effect on January 1, 2022. ======== LC001009 ========- This act would provide that health plans that provide coverage for prescription insulin drugs used to treat diabetes shall only be allowed to charge up to forty dollars ($40.00) for a copayment for a thirty (30) day supply of insulin regardless of the amount or type of insulin needed to fill the covered person's prescription. Coverage for prescription insulin would not be subject to any deductible.
- This act would take effect on January 1, 2022. ======== LC001009/SUB B ========
Votes
NOTE: Electronic voting records are unofficial and may not be accurate. For an official vote tally, check the
House or Senate Journal from the day of the vote.
June 01, 2021 at 4:34pm
Yeas: 36 /
Nays: 0 /
Not voting: 2 /
Recused: 0
June 29, 2021 at 3:31pm
Yeas: 37 /
Nays: 0 /
Not voting: 1 /
Recused: 0